share_log

BRIEF-Cybin Acquires Dmt Clinical Study From Entheon Biomedical

reuters ·  Jun 7, 2022 09:05

June 7 (Reuters) - Cybin Inc CYBN.NLB :

* CYBIN ACQUIRES DMT CLINICAL STUDY FROM ENTHEON BIOMEDICAL

* CYBIN INC- PURCHASE PRICE OF ACQUISITION IS $1,000,000 (CAD)

Source text for Eikon: ID:nBw20D4Bma Further company coverage: CYBN.NLB

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment